Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordyn Silverstein

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 15, 2022
Invited Commentary: Role of the Radiologist in Pregnancy-associated CancerJordyn Silverstein, Katherine Van Loon
JAMA Oncology|September 21, 2023
Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than AnswersJordyn Silverstein, Katherine Van Loon
JAMA Oncology|August 11, 2022
The Implications of the Supreme Court Decision to Overturn Roe v Wade for Women With Pregnancy-Associated CancersJordyn Silverstein, Katherine Van Loon
Current Oncology Reports|May 23, 2024
For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic TherapyJordyn Silverstein, Neha Goyal, Katy K Tsai
Current Opinion in Obstetrics & Gynecology|October 31, 2024
Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025Jordyn Silverstein, Beth Karlan, Nasim Herrington, et al.
Future Oncology (London, England)|June 12, 2025
Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancerJordyn Silverstein, Alexandra Smick, Bridget Johnson, et al.
Current Opinion in Obstetrics & Gynecology|December 29, 2025
Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancerShivani K Thaker, Jordyn Silverstein, Gottfried E Konecny, et al.
Abdominal Radiology (New York)|January 27, 2023
The radiologist's role in a multidisciplinary approach to cancer in pregnancyJoelle Harwin, Priyanka Jha, Annalisa Post, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 8, 2025
Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure on outcomesAlexandra H Smick, Lindsay Brennan, Jordyn Silverstein, et al.
Journal of the National Cancer Institute|April 18, 2026
Oncofertility patterns after the overturn of Roe v. WadeNikita V Baclig, Jordyn Silverstein, Vrushangi Shah, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 15, 2022
Invited Commentary: Role of the Radiologist in Pregnancy-associated CancerJordyn Silverstein, Katherine Van Loon
JAMA Oncology|September 21, 2023
Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than AnswersJordyn Silverstein, Katherine Van Loon
JAMA Oncology|August 11, 2022
The Implications of the Supreme Court Decision to Overturn Roe v Wade for Women With Pregnancy-Associated CancersJordyn Silverstein, Katherine Van Loon
Current Oncology Reports|May 23, 2024
For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic TherapyJordyn Silverstein, Neha Goyal, Katy K Tsai
Current Opinion in Obstetrics & Gynecology|October 31, 2024
Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025Jordyn Silverstein, Beth Karlan, Nasim Herrington, et al.
Future Oncology (London, England)|June 12, 2025
Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancerJordyn Silverstein, Alexandra Smick, Bridget Johnson, et al.
Current Opinion in Obstetrics & Gynecology|December 29, 2025
Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancerShivani K Thaker, Jordyn Silverstein, Gottfried E Konecny, et al.
Abdominal Radiology (New York)|January 27, 2023
The radiologist's role in a multidisciplinary approach to cancer in pregnancyJoelle Harwin, Priyanka Jha, Annalisa Post, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 8, 2025
Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure on outcomesAlexandra H Smick, Lindsay Brennan, Jordyn Silverstein, et al.
Journal of the National Cancer Institute|April 18, 2026
Oncofertility patterns after the overturn of Roe v. WadeNikita V Baclig, Jordyn Silverstein, Vrushangi Shah, et al.
Pageof 3